2-Fluorodeschloroketamine: Difference between revisions
>Unity Added some details to introduction. |
>Unity Imported interactions from ketamine. |
||
Line 122: | Line 122: | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
{{DangerousInteractions/Intro}} | {{DangerousInteractions/Intro}} | ||
*'''[[UncertainInteraction::Benzodiazepines]]''' - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. | |||
*'''[[UncertainInteraction::MAOIs]]''' - MAO-B inhibitors appear to increase the potency of ketamine. MAO-A inhibitors have some negative reports associated with the combination but there isn't much information available | |||
*'''[[DangerousInteraction::Alcohol]]''' - Both substances cause ataxia and bring a very high risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position. | |||
*'''[[DangerousInteraction::GHB]]''' - Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position. | |||
*'''[[DangerousInteraction::GBL]]''' - Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position. | |||
*'''[[DangerousInteraction::Opioids]]''' - Both substances bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position. | |||
*'''[[DangerousInteraction::Tramadol]]''' - Potential increased risk of seizures. | |||
*'''Grapefruit''' - Grapefruit juice significantly increases oral absorption of ketamine. This may result in the user having double the concentration of ketamine in their system compared to normal. The ketamine may also have a longer duration of effect.<ref>[https://www.ncbi.nlm.nih.gov/pubmed/22286159]</ref> It is likely that this property extends to 2F-DCK as well. | |||
==Legal status== | ==Legal status== |